Magnesium Deficiency Clinical Trial
Official title:
Preoperative Ionized Magnesium Assessment in Adults: an Observational Study on the Prevalence of Hypomagnesemia
NCT number | NCT04972344 |
Other study ID # | B-2106-688-304 |
Secondary ID | |
Status | Completed |
Phase | |
First received | |
Last updated | |
Start date | July 27, 2021 |
Est. completion date | April 11, 2022 |
Verified date | April 2022 |
Source | Seoul National University Bundang Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The reported incidence of hypomagnesemia is approximately 2% in the general population. Hypomagnesemia is a common problem, occurring in nearly 10%of general hospitalized patients and 17% of hospitalized cancer patients. A higher incidence, up to 60% to 65%, has been found among intensive care unit patients. Hypomagnesemia can potentially cause fatal complications including ventricular arrhythmia, coronary artery spasm, and sudden death. It also associates with increased mortality and prolonged hospitalization. Magnesium exists in three different forms in the body. In serum, 5-14% of the magnesium is reported to be complexed with anions such as phosphate, bicarbonate, and citrate, 19-33% is reported to be protein-bound (mainly to albumin), and 55-67% is found in the free ionized fraction. Because the amount of bound or complexed Mg can vary significantly, especially in illness, the ionized magnesium can vary in an unpredictable way. Conventional laboratory testing typically only measures total serum magnesium, which is often not reflective of ionized magnesium. Unlike ionized calcium, which is commonly measured and is also readily calculated from the total calcium and albumin levels, ionized magnesium is neither commonly measured nor easily calculated. One study reported that the level of ionized magnesium cannot be predicted by analysis of total magnesium and that the levels of ionized magnesium vary upon different pathophysiological conditions and between individuals. Furthermore, measurement of ionized magnesium in serum might be of great impact in patients for whom magnesium status is required, and the correlation of ionized magnesium and total magnesium is weak in patients for whom magnesium status is required as a whole, and this is the reason why the ionized magnesium should be measured directly. To date, most of the clinical studies were evaluate the effect of hypomagnesemia on the outcome after surgery using the levels of total serum magnesium. However, the portion of extracellular magnesium that is physiologically active is in the various process is ionized magnesium. So, it is important to evaluate the level of ionized magnesium in surgical patients to predict the outcomes after surgery. Unfortunately, clinical trial regarding the effect of the concentrations of ionized magnesium on the surgical patients is limited.
Status | Completed |
Enrollment | 536 |
Est. completion date | April 11, 2022 |
Est. primary completion date | March 18, 2022 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 19 Years to 90 Years |
Eligibility | Inclusion Criteria: - Patients undergoing surgery - Aged = 19 - Fasted = 8 hours Exclusion Criteria: - Chronic kidney disease - Aged < 19 - Fasted < 8 hours - Patients who were taking magnesium |
Country | Name | City | State |
---|---|---|---|
Korea, Republic of | Seoul National University Bundang Hospital | Seongnam-si | Gyeonggi-do |
Lead Sponsor | Collaborator |
---|---|
Seoul National University Bundang Hospital |
Korea, Republic of,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Ionized magnesium | Assess the ionized magnesium level | within 10 minutes after induction of anesthesia; 10 minutes before the end of surgery | |
Secondary | total magnesium | Assess the total magnesium level | within 10 minutes after induction of anesthesia |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04130620 -
Validation of the Magnesium Muscle Stretch Test
|
||
Completed |
NCT01593501 -
How Does Magnesium Status Influence Calcium Homeostasis?
|
Phase 4 | |
Recruiting |
NCT04942119 -
Impact of Long-term Serum Magnesium and Potassium Levels Optimization and Multifactorial Adherence Intervention on the Progression of Diabetic Kidney Disease.
|
N/A | |
Recruiting |
NCT05149820 -
Point of Care RandOmisation Systems for Performing Embedded Comparative Effectiveness Trials Of Routine Treatments
|
Phase 4 | |
Completed |
NCT02032186 -
A Randomized Clinical Trial of Oral Magnesium Supplementation in Pregnancy
|
Phase 3 | |
Completed |
NCT04216836 -
One Week of Magnesium Supplementation Lowers IL-6, Perceived Pain and Increases Post Exercise Blood Glucose in Response to Downhill Running
|
N/A | |
Completed |
NCT03353636 -
Bioavailability of Magnesium Supplements
|
N/A | |
Completed |
NCT02719925 -
Mineral Water Rich in Magnesium and Perceived Stress in Healthy Consumers
|
N/A | |
Completed |
NCT05630339 -
Magnesium and Vitamin D Combination for Post-COVID Syndrome
|
N/A | |
Completed |
NCT03554668 -
Systemic Inflammatory Response: Thiamine and Magnesium Status (Sir TaM Study)
|
||
Recruiting |
NCT05271838 -
Protein and Magnesium in Ulcerative Colitis
|
N/A | |
Completed |
NCT03134417 -
Magnesium and Vitamin D Supplementation and Cardiometabolic Outcomes
|
N/A | |
Active, not recruiting |
NCT02674789 -
Ionized Magnesium in Athletes
|
N/A | |
Completed |
NCT03466528 -
Alcohol: Thiamine and or Magnesium 1
|
Phase 2/Phase 3 | |
Recruiting |
NCT03840226 -
The Impact of Magnesium on Exercise Tolerance, Quality of Life and Clinical Outcomes in Chronic Heart Failure Patients
|
Phase 3 | |
Terminated |
NCT03471481 -
Magnesium as a Mediator of Bone and Vitamin D Metabolism in Patients on Antiepileptic Drug Therapy
|